The Lost or Absence of MRD<0.1% at Any Time after 2 Cycles of Consolidation Chemotherapy in CBFB-MYH11-Positive Acute Myeloid Leukemia Indicates Poor Prognosis

被引：0

作者：

Duan, Wenbing ^{[1
]}

Jia, Jinsong ^{[1
]}

Wang, Jing ^{[1
]}

Liu, Xiaohong ^{[1
]}

Gong, Lizhong ^{[1
]}

Jiang, Qian ^{[1
]}

Zhao, Ting ^{[1
]}

Wang, Yu ^{[2
]}

Zhang, Xiaohui ^{[1
]}

Xu, Lanping ^{[2
]}

Liu, Yanrong ^{[1
]}

Qin, Yazhen ^{[1
]}

Huang, Xiaojun ^{[1
]}

Jiang, Hao ^{[1
]}

机构：

[1] Peking Univ Peoples Hosp, Peking Univ Inst Hematol, Natl Clin Res Ctr Hematol Dis, Beijing, Peoples R China

[2] Peking Univ, Peking Univ Peoples Hosp, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Peking Univ Inst Hematol, Beijing, Peoples R China

来源：

关键词：

D O I：

10.1182/blood-2019-126938

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2616

引用

页数：3

The Lost or Absence of MRD&lt;0.1% at Any Time after 2 Cycles of Consolidation Chemotherapy in CBFB-MYH11-Positive Acute Myeloid Leukemia Indicates Poor Prognosis